Immunological Barriers to Embryonic Stem Cell-Derived Therapies

Publisher： Karger

E-ISSN： 1422-6421|188|1-2|78-90

ISSN： 1422-6405

Source： Cells Tissues Organs, Vol.188, Iss.1-2, 2008-02, pp. : 78-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Embryonic Stem Cell-Derived Adipogenesis

By  

Cells Tissues Organs, Vol. 165, Iss. 3-4, 1999-12 ,pp. : 173-180

Karger

Access to resources Recommend Favorite

Embryonic Stem Cell-Derived Haematopoiesis

By  

Cells Tissues Organs, Vol. 165, Iss. 3-4, 1999-12 ,pp. : 181-189

Karger

Access to resources Recommend Favorite

Human embryonic stem cell-derived cardiomyocytes: drug discovery and safety pharmacology

By He Jia-Qiang   January Craig T   Thomson James A   Kamp Timothy J  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 5, 2007-05 ,pp. : 739-753

Informa Healthcare

Access to resources Recommend Favorite

Portrayal of the Notch System in Embryonic Stem Cell-Derived Embryoid Bodies

By  

Cells Tissues Organs, Vol. 193, Iss. 4, 2010-11 ,pp. : 239-252

Karger

Access to resources Recommend Favorite

Phenotypic and Differentiation Stability of Human Embryonic Stem Cell-Derived Osteoblasts

By  

Cells Tissues Organs, Vol. 194, Iss. 2-4, 2011-05 ,pp. : 326-330

Karger

Access to resources Recommend Favorite